Based on the Fevertree Drinks Plc stock forecast from 1 analysts, the average analyst target price for Fevertree Drinks Plc is GBX 1,200.00 over the next 12 months. Fevertree Drinks Plc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Fevertree Drinks Plc is Bearish, which is based on 2 positive signals and 12 negative signals. At the last closing, Fevertree Drinks Plc’s stock price was GBX 1,075.00. Fevertree Drinks Plc’s stock price has changed by -2.98% over the past week, -2.89% over the past month and -15.15% over the last year.
No recent analyst target price found for Fevertree Drinks Plc
No recent average analyst rating found for Fevertree Drinks Plc
Company Overview Fevertree Drinks Plc
Fevertree Drinks Plc, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. The company offers Indian, Mediterranean, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; gingers; sodas; cola and lemonades; cocktails; and sparkling soft drinks. It sells its products under Fever-Tree brand name to bars and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was founded in 2004 and is headquartered in London, the United Kingdom. Read Less
Fevertree Drinks Plc, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. The company offers Indian, Mediterranean, elderflower, cucumber, damson and sloe berry,...Read More
Frequently Asked Questions About Fevertree Drinks Plc (FEVR:LSE) Stock
Based on ratings from 1 analysts Fevertree Drinks Plc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
FEVR:LSE stock's dividend yield is 1.39%.
Our analysis grades FEVR:LSE stock's dividend yield at F. This means that FEVR:LSE stock's dividend yield is above 17% of the stocks in the Beverages - Non-Alcoholic sector in the LSE exchange.
Based on this FEVR:LSE may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for FEVR:LSE is GBX 1,200.00 over the next 12 months. The maximum analyst target price is GBX 1200 while the minimum anlayst target price is GBX 1200.
FEVR:LSE stock's Price/Earning ratio is 92.38.
Our analysis grades FEVR:LSE stock's Price / Earning ratio at F. This means that FEVR:LSE stock's Price/Earning ratio is above 83% of the stocks in the Beverages - Non-Alcoholic sector in the LSE exchange.
Based on this FEVR:LSE may be a overvalued for its sector.
The last closing price of FEVR:LSE's stock was GBX 1,075.00.
The most recent market capitalization for FEVR:LSE is GBX 1.40B.
Based on targets from 1 analysts, the average taret price for FEVR:LSE is projected at GBX 1,200.00 over the next 12 months.
This means that FEVR:LSE's stock price may go up by +11.63% over the next 12 months.
We can't find any ETFs which contains Fevertree Drinks Plc's stock.
As per our most recent records Fevertree Drinks Plc has 0 Employees.
Fevertree Drinks Plc's registered address is 186 -188 Shepherds Bush Road, London, United Kingdom, W6 7NL.
You can get more information about it from Fevertree Drinks Plc's website at https://www.fever-tree.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FEVR:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
